Zhejiang Starry Pharmaceutical Co.,Ltd. (SHA:603520)

SHA:603520 Revenue

Zhejiang Starry Pharmaceutical had revenue of 447.26M CNY in the quarter ending September 30, 2025, a decrease of -5.66%. This brings the company's revenue in the last twelve months to 2.39B, up 0.89% year-over-year. In the year 2024, Zhejiang Starry Pharmaceutical had annual revenue of 2.35B with 7.02% growth.

• Revenue (ttm): 2.39B
• Revenue Growth: +0.89%
• P/S Ratio: 2.18
• Revenue / Employee: 1.36M
• Employees: 1,754
• Market Cap: 5.22B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2024	2.35B	154.24M	7.02%
Dec 31, 2023	2.20B	64.75M	3.04%
Dec 31, 2022	2.13B	131.32M	6.57%
Dec 31, 2021	2.00B	632.83M	46.29%
Dec 31, 2020	1.37B	58.25M	4.45%

Data Source: S&P Global Market Intelligence Last updated: Sep 30, 2025

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

Apr 27, 2026

Data Sources Report a data error